Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Fosravuconazole by Eisai for Tinea Pedis (Athlete Foot): Likelihood of Approval
Fosravuconazole is under clinical development by Eisai and currently in Phase II for Tinea Pedis (Athlete Foot). According to GlobalData,...